Skip to content

Clinical trials

Observational Diabetes Mellitus trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Diabetes Mellitus Phase: Observational Country / region: China Clear all

134 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20062
20072
20086
20095
20108
20113
20126
20133
20142
20153
20166
20178
20185
20195
20207
202110
202212
20236
202418
202512
20264

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed53
Unknown status39
Recruiting23
Not yet recruiting7
Active, not recruiting5
Enrolling by invitation3
Withdrawn2
Suspended1
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novo Nordisk A/S8
Shanghai Zhongshan Hospital5
Xijing Hospital5
Changhai Hospital4
Chinese University of Hong Kong4
Guangdong Provincial People's Hospital4
Ruijin Hospital4
Bayer3
China Cardiometabolic Registries3
Peking Union Medical College Hospital3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Diabetes Mellitus134
Diabetes Mellitus, Type 220
Hypertension20
Cardiovascular Diseases14
Renal Insufficiency, Chronic10
Obesity9
Diabetes Mellitus, Type 16
Insulin Resistance6
Metabolic Diseases6
Metabolic Syndrome6

Trials

Showing 1 to 25 of 134. Each trial links to its page on Pharma Observatory.

34 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.